#AMR poses an increasing threat to #rural communities in the U.S.

Our new white paper explores how workforce shortages, environmental exposures, and limited access to diagnostics and antibiotics, are amplifying infection risks across rural communities. www.amractionfund.com/blog/white-p...

23.10.2025 16:55 — 👍 1    🔁 0    💬 1    📌 0

Stop playing catch-up with superbugs: the anticipatory governance of antimicrobial resistance Antimicrobial resistance (AMR) threatens lives, healthcare systems and the global economy. But anticipatory governance that reshapes responses can get ahead of the problem

"Anticipatory governance emphasizes foresight, inclusiveness and adaptive policy to address risks before they escalate to insurmountable crises" and could provide a framework through which to address #AMR. via WEF by AMR Action Fund's Deepali Patel www.weforum.org/stories/2025...

15.10.2025 11:53 — 👍 0    🔁 0    💬 0    📌 0

A new antibiotic is positive news—but it will take more to stay ahead of superbugs Antibiotic resistance is one of the biggest health threats of our time—and tackling it will take more than a single breakthrough, writes Nicola Rose The Medicines and Healthcare Products Regulatory ...

"The problem is that many UTIs no longer respond to the antibiotics we’ve relied on for decades: more than 90% of UTI causing bacteria are now resistant to at least one common medicine." #AMR www.bmj.com/content/391/... via @bmj.com

14.10.2025 12:32 — 👍 0    🔁 0    💬 0    📌 0

A new @who.int report finds that 1 in 6 lab-confirmed bacterial infections in 2023 were resistant to antibiotics. E. coli and K. pneumoniae are the leading drug-resistant Gram-negative bacteria found in bloodstream infections. www.who.int/news/item/13... #AMR

13.10.2025 16:27 — 👍 1    🔁 1    💬 1    📌 0

For people with #cancer, infections have long been a scourge. The rise of #AMR is rapidly undermining cancer care, with studies showing that AMR rates for key pathogens are 1.2-5x greater in isolates from cancer outpatients vs non-cancer patients. antimicrobialresistancefighters.org/cancer-and-a...

08.10.2025 12:31 — 👍 0    🔁 0    💬 1    📌 0

The @who.int released its new antibacterial pipeline analysis today and the findings are once again cause for concern. Total # of clinical-stage assets is down and only 11 agents are in development for critical priority pathogens. Read the full report www.statnews.com/wp-content/u... #AMR

02.10.2025 15:32 — 👍 0    🔁 0    💬 0    📌 0